Could Your Smartphone Predict Your Next Flare?
For those living with autoimmune diseases, the unpredictable nature of "flares"—sudden increases in joint pain, stiffness, and fatigue—can make daily planning a challenge. However, new research reported in ACR Open Rheumatology suggests that the device already in our pockets might offer early warning signs. By analyzing subtle changes in how we use our smartphones, researchers are finding that digital data can detect a flare before a patient even realizes it’s coming.
The study looked at "digital precursors"—small, measurable changes in behavior captured by smartphone sensors—in patients with rheumatoid arthritis (RA). These include things like typing speed, the frequency of screen interactions, and physical movement tracked via GPS and accelerometers. When a flare begins to develop, these behaviors often shift slightly; for example, a person might move less or take longer to type a text message due to emerging stiffness or fatigue. These changes may be so subtle that patients don’t realize they are already experiencing the initial symptoms of a flare.
What makes this discovery so exciting is its potential for passive monitoring. Unlike traditional symptom journals that require patients to manually log their pain every day, this technology runs in the background. By identifying these patterns early, the goal is to provide a "weather forecast" for our health. This could allow patients to adjust their activities, prioritize rest, or consult their doctor to tweak their treatment before the full onset of flare symptoms.
During the study, 292 patients consented to sharing their mobile data and filling out patient-reported outcomes (PRO) through a daily questionnaire. The study was then split into 2 phases: a “conditional” phase where patients were only asked flare-related questions when their daily PROs showed worsening symptoms, and a “fixed” phase where patients were asked flare-related questions every 2 weeks regardless of their daily PROs. Results from the 2 phases showed similar results. The conditional phase found that when patients moved farther and had shorter text response times, they were less likely to experience flares. The fixed phase found that longer text messages were associated with a reduced risk of flares. Overall, it appears that before the full onset of flare symptoms, minor signs were already beginning to manifest in patients in the form of less mobility, slower reaction time, and shorter text messages.
While this technology is still in the developmental and testing phases, it represents a major shift toward personalized, proactive medicine. Instead of reacting to symptoms after they become severe, doctors and patients may soon have the tools to stay one step ahead by intervening with earlier treatment and potentially reducing flare severity. It’s a promising glimpse into a future where managing chronic conditions is supported by the smart technology we use every day.
To support the Autoimmune Registry, please share our information with others who have autoimmune diseases. Donations are also greatly appreciated!
